Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 23 min ago
PreprintCC BYChemRxiv

Atomic-level structure of an amorphous solid dispersion

9 affiliations
  1. 1Institut des Sciences et Ingénierie Chimiques
  2. 2École Polytechnique Fédérale de Lausanne (EPFL
  3. 3National Centre for Computational Design and Discovery of Novel Materials MARVEL
  4. 4Sustainable Innovation & Transformational Excellence, Pharmaceutical Technology & Development, Operations
  5. 5AstraZeneca
  6. 6Predictive Science, Digital and Automation, Pharmaceutical Sciences
  7. 7R&D, AstraZeneca
  8. 8Global Product Development, Pharmaceutical Technology & Development, Operations
  9. 9Early Product Development and Manufacturing, Pharmaceutical Sciences

Abstract

Amorphous materials play a pivotal role across condensed-matter physics, materials science, and pharmaceuticals, for example enabling increased dissolution rates and higher in-vivo exposure for poorly bioavailable molecules. In particular, amorphous solid dispersions (ASDs), disordered multi-component mixtures of an active ingredient within a polymer matrix, are widely used to trap molecules in metastable high-energy states. However, because these systems lack longrange order, directly observing their atomic-level spatial arrangements has remained an outstanding challenge, rendering their long-term physical stability unpredictable and leaving formulation science reliant on empirical screening. Here we report the first complete three-dimensional, atomic-level structure elucidation of an amorphous solid dispersion. By combining solid-state NMR crystallography with machine-learning-accelerated quantum chemical calculations, we determine the structural ensemble of the drug AZD5462 within a copovidone matrix. We show that the polymer drives a total reconfiguration of the hydrogen-bonding network, substituting self-association with API–polymer interactions and fundamentally altering the local conformational energy landscape by raising the kinetic barriers to rearrangement. The structure explains why the formulation remains physically stable for over two years, whereas the pure amorphous drug recrystallizes within hours. These findings establish a rigorous structural framework for disordered multi-component materials, paving the way for the rational, structure-directed design of amorphous matter.

Related

  1. Analysis of the pH-Dependent Phase Behavior of Amorphous Solid Dispersions Using in situ Stimulated Raman Scattering Microscopy
    Aino Majanen, Clare Strachan, Teemu Tomberg
    ChemRxivPreprintCC BY-NCFull textPharmacology & toxicologyChemRxiv
  2. Gamma-Oryzanol Solid Dispersion Attenuates Dexamethasone-Induced Depressive-like Behaviors in Rats Associated with Calbindin-1 and Calcium Signaling.
    Siripaporn Kesyou, Waree Tiyaboonchai, Jureepon Roboon +7
    International journal of molecular sciencesPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  3. Formulation and characterization of solid dispersion adsorbate of Candesartan Cilexetil: in vitro dissolution and in vivo performance
    Harshad Makwana, Anjali Patel, Manisha Lalan +5
    Frontiers in Drug DeliveryPeer-reviewedCC BYFull textPharmacology & toxicologyDOAJ
  4. Associations of County-Level Urbanicity With Overall Survival Across 19 Solid Tumor Groups, 2004–2023: A SEER Cohort Study of 5.5 Million Patients
    Lihui Liang, Jiancheng Huang, Qingbai Jiang
    Cancer Control: Journal of the Moffitt Cancer CenterPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  5. Quantitative CT definition of solid components in pulmonary ground-glass nodules: a pixel-level annotation-based development and internal validation study.
    Yuhao Chen, Nan Chen, Yuhuan Ye +9
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
BibTeX
@misc{holmes2026atomiclevel,
  title = {{Atomic-level structure of an amorphous solid dispersion}},
  author = {Jacob B. Holmes and Daria Torodii and Tommaso Casalini and Ruben Rodriguez-Madrid and Sten O. Nilsson Lill and Anna Svensk Ankarberg and Okky Dwichandra Putra and Staffan Schantz and Lyndon Emsley},
  howpublished = {ChemRxiv},
  year = {2026},
  month = oct,
  doi = {10.26434/chemrxiv.15010694/v1},
  url = {https://chemrxiv.org/doi/full/10.26434/chemrxiv.15010694/v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Atomic-level structure of an amorphous solid dispersion
AU  - Jacob B. Holmes
AU  - Daria Torodii
AU  - Tommaso Casalini
AU  - Ruben Rodriguez-Madrid
AU  - Sten O. Nilsson Lill
AU  - Anna Svensk Ankarberg
AU  - Okky Dwichandra Putra
AU  - Staffan Schantz
AU  - Lyndon Emsley
PY  - 2026
DA  - 2026/10/20
PB  - ChemRxiv
DO  - 10.26434/chemrxiv.15010694/v1
UR  - https://chemrxiv.org/doi/full/10.26434/chemrxiv.15010694/v1
AB  - Amorphous materials play a pivotal role across condensed-matter physics, materials science, and pharmaceuticals, for example enabling increased dissolution rates and higher in-vivo exposure for poorly bioavailable molecules. In particular, amorphous solid dispersions (ASDs), disordered multi-component mixtures of an active ingredient within a polymer matrix, are widely used to trap molecules in metastable high-energy states. However, because these systems lack longrange order, directly observing their atomic-level spatial arrangements has remained an outstanding challenge, rendering their long-term physical stability unpredictable and leaving formulation science reliant on empirical screening. Here we report the first complete three-dimensional, atomic-level structure elucidation of an amorphous solid dispersion. By combining solid-state NMR crystallography with machine-learning-accelerated quantum chemical calculations, we determine the structural ensemble of the drug AZD5462 within a copovidone matrix. We show that the polymer drives a total reconfiguration of the hydrogen-bonding network, substituting self-association with API–polymer interactions and fundamentally altering the local conformational energy landscape by raising the kinetic barriers to rearrangement. The structure explains why the formulation remains physically stable for over two years, whereas the pure amorphous drug recrystallizes within hours. These findings establish a rigorous structural framework for disordered multi-component materials, paving the way for the rational, structure-directed design of amorphous matter.
ER  -